Public Health
All adults in the US are now eligible for COVID-19 vaccines
In the U.S., anyone over the age of 16 is now eligible for COVID-19 vaccines — a major milestone along the path to herd immunity.
Food supplement appears to “cure” malnutrition in children
A food supplement designed to cure malnutrition in children doesn’t just deliver calories — it also helps promote a healthy gut microbiome.
New approach for mRNA HIV vaccine passes first human trial
There is currently no HIV vaccine, but a new technique which produced specific immunity cells in humans may pave the way to one.
Pfizer’s COVID-19 vaccine 100% effective in adolescent study
Pfizer’s COVID-19 vaccine was reportedly 100% effective in a trial involving more than 2,000 adolescents between the ages of 12 and 15.
A common virus may be the key to a COVID vaccine for young children
Researchers have reverse-engineered a common children’s virus to show the spike protein, potentially leading to a new COVID vaccine for young children.
US will spend $1 billion studying long COVID
The U.S. is dedicating $1.15 billion to studying long COVID, a condition in which survivors experience long-term effects of COVID-19.
New test can show if you’ve had COVID-19, even if antibodies fade
The FDA has approved a T cell test for COVID, a first-of-its-kind assay that looks to the immune system’s memory.
Can RNA create a malaria vaccine?
An effective malaria vaccine could save hundreds of thousands of lives each year. Can RNA vaccines like the ones fighting SARs-CoV-2 tackle another disease?
Smartphones can track your blood sugar levels
The ability to easily monitor blood sugar levels would allow everyone to have more control over their own metabolic health — not just people with diabetes.
Cone snail venom may help treat malaria
Clumps of infected red blood cells can make malaria dangerous even after its parasite is treated. Cone snail venom may one day help.